Related Experiment Video
Updated: Dec 7, 2025

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
API-ISG Consensus Guidelines for Management of Gastrooesophageal Reflux Disease
Shobna Bhatia1, K K Pareek2, Ajay Kumar3
1Professor, Department of Gastroenterology, H.N. Reliance Hospital, Mumbai, Maharashtra.
Gastroesophageal reflux disease (GERD) affects about 10% of adults in India, with prevalence increasing due to lifestyle changes. Diagnosis relies on symptoms, and proton pump inhibitors (PPIs) are effective, with invasive tests reserved for refractory cases.
Area of Science:
- Gastroenterology
- Internal Medicine
- Public Health
Background:
- Gastroesophageal reflux disease (GERD) is a prevalent community health issue.
- Lifestyle changes and rising obesity rates in India are contributing to an increase in GERD prevalence.
- Existing guidelines are crucial for standardized GERD management.
Purpose of the Study:
- To establish evidence-based practice guidelines for adult GERD management in India.
- To provide consensus statements on GERD epidemiology, presentation, investigation, treatment, and complications.
- To offer a framework for healthcare professionals managing GERD patients.
Main Methods:
- A modified Delphi process involving electronic voting and face-to-face meetings.
- Review of supporting literature, with a primary focus on Indian studies.
- Development of 43 consensus statements covering various aspects of GERD.
Main Results:
- GERD prevalence in India is approximately 10%, with an upward trend.
- Diagnosis in the community should primarily be based on classical symptoms (heartburn, sour regurgitation).
- Empiric treatment with proton pump inhibitors (PPIs) or H2 receptor antagonists is recommended; equipotent PPI doses show similar efficacy.
Conclusions:
- Community diagnosis of GERD should prioritize symptom-based assessment and empiric treatment.
- Proton pump inhibitors are effective for GERD symptom management.
- Invasive investigations are indicated only for patients with alarm symptoms or PPI-refractory GERD.
More Related Videos
08:25Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
04:09Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Irritable Bowel Syndrome III: Medical and Nursing Management
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology